INTEGRA LIFESCIENCES HOLDINGS CORP Sales Revenue, Goods, Net (Deprecated 2018-01-31)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $357.08 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-04-26
- INTEGRA LIFESCIENCES HOLDINGS CORP sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $357.08M, a 38.06% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $368.60M, a 44.17% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $278.83M, a 11.39% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $282.16M, a 13.18% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $1.19B, a 19.77% increase from fiscal 2016.
- INTEGRA LIFESCIENCES HOLDINGS CORP sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $992.08M, a 12.39% increase from fiscal 2015.
- INTEGRA LIFESCIENCES HOLDINGS CORP sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $882.73M, a 10.80% increase from fiscal 2014.
- INTEGRA LIFESCIENCES HOLDINGS CORP sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $796.72M, a 14.33% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $357.08M 10-Q · filed 2018-04-26 | $725.68M derived: sum of 2 quarters · filed 2018-04-26 | $1.00B derived: sum of 3 quarters · filed 2018-04-26 | $1.29B derived: sum of 4 quarters · filed 2018-04-26 | ||||
| 2017-12-31 | $368.60M 10-K · filed 2018-03-01 | $647.44M derived: sum of 2 quarters · filed 2018-03-01 | $929.60M derived: sum of 3 quarters · filed 2018-03-01 | $1.19B 10-K · filed 2018-03-01 | ||||
| 2017-09-30 | $278.83M 10-K · filed 2018-03-01 | $561.00M derived: sum of 2 quarters · filed 2018-03-01 | $819.63M 10-Q · filed 2017-10-26 | $1.08B derived: sum of 4 quarters · filed 2018-04-26 | ||||
| 2017-06-30 | $282.16M 10-K · filed 2018-03-01 | $540.80M 10-Q · filed 2017-07-26 | $796.46M derived: sum of 3 quarters · filed 2018-04-26 | $1.05B derived: sum of 4 quarters · filed 2018-04-26 | ||||
| 2017-03-31 | $258.64M 10-Q · filed 2018-04-26 | $514.30M derived: sum of 2 quarters · filed 2018-04-26 | $764.63M derived: sum of 3 quarters · filed 2018-04-26 | $1.01B derived: sum of 4 quarters · filed 2018-04-26 | ||||
| 2016-12-31 | $255.66M 10-K · filed 2018-03-01 | $506.00M derived: sum of 2 quarters · filed 2018-03-01 | $755.30M derived: sum of 3 quarters · filed 2018-03-01 | $992.08M 10-K · filed 2018-03-01 | ||||
| 2016-09-30 | $250.33M 10-K · filed 2018-03-01 | $499.64M derived: sum of 2 quarters · filed 2018-03-01 | $736.41M 10-Q · filed 2017-10-26 | $977.57M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $249.31M 10-K · filed 2018-03-01 | $486.08M 10-Q · filed 2017-07-26 | $727.24M derived: sum of 3 quarters · filed 2018-03-01 | $953.61M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $236.77M 10-K · filed 2018-03-01 | $477.93M derived: sum of 2 quarters · filed 2018-03-01 | $704.30M derived: sum of 3 quarters · filed 2018-03-01 | $916.97M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $241.16M 10-K · filed 2017-02-23 | $467.53M derived: sum of 2 quarters · filed 2017-02-23 | $680.20M derived: sum of 3 quarters · filed 2017-02-23 | $882.73M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $226.37M 10-K · filed 2017-02-23 | $439.04M derived: sum of 2 quarters · filed 2017-02-23 | $641.57M 10-Q · filed 2016-10-28 | $860.65M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $212.67M 10-K · filed 2017-02-23 | $244.08M 10-Q · filed 2015-07-31 | $415.21M 10-Q · filed 2016-07-28 | $477.74M 10-Q · filed 2015-07-31 | $634.28M derived: sum of 3 quarters · filed 2017-02-23 | $831.80M derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-03-31 | $202.53M 10-K · filed 2017-02-23 | $233.66M 10-Q · filed 2015-05-01 | $421.61M derived: sum of 2 quarters · filed 2017-02-23 | $619.13M derived: sum of 3 quarters · filed 2017-02-23 | $816.17M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | $219.07M 10-K · filed 2016-02-26 | $252.18M 10-K · filed 2015-02-27 | $416.60M derived: sum of 2 quarters · filed 2016-02-26 | $613.64M derived: sum of 3 quarters · filed 2016-02-26 | $796.72M 10-K · filed 2017-02-23 | $928.30M 10-K · filed 2015-02-27 | ||
| 2014-09-30 | $197.52M 10-K · filed 2016-02-26 | $229.72M 10-Q · filed 2014-11-07 | $394.57M derived: sum of 2 quarters · filed 2016-02-26 | $577.64M 10-Q · filed 2015-11-04 | $676.13M 10-Q · filed 2014-11-07 | $798.41M derived: sum of 4 quarters · filed 2016-02-26 | ||
| 2014-06-30 | $197.04M 10-K · filed 2016-02-26 | $231.35M 10-Q · filed 2014-08-05 | $446.41M 10-Q · filed 2015-07-31 | $600.89M derived: sum of 3 quarters · filed 2016-02-26 | $814.13M derived: sum of 4 quarters · filed 2016-02-26 | |||
| 2014-03-31 | $183.08M 10-K · filed 2016-02-26 | $215.06M 10-Q · filed 2014-05-01 | $403.85M derived: sum of 2 quarters · filed 2016-02-26 | $617.09M derived: sum of 3 quarters · filed 2016-02-26 | $822.64M derived: sum of 4 quarters · filed 2016-02-26 | |||
| 2013-12-31 | $220.77M 10-K · filed 2015-02-27 | $434.01M derived: sum of 2 quarters · filed 2015-02-27 | $639.56M derived: sum of 3 quarters · filed 2015-02-27 | $696.83M 10-K · filed 2016-02-26 | $836.21M 10-K · filed 2014-02-27 | |||
| 2013-09-30 | $213.25M 10-K · filed 2015-02-27 | $418.79M derived: sum of 2 quarters · filed 2015-02-27 | $615.45M 10-Q · filed 2014-11-07 | $829.88M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $205.55M 10-K · filed 2015-02-27 | $402.20M 10-Q · filed 2014-08-05 | $616.63M derived: sum of 3 quarters · filed 2015-02-27 | $826.72M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $196.65M 10-K · filed 2015-02-27 | $411.08M derived: sum of 2 quarters · filed 2015-02-27 | $621.17M derived: sum of 3 quarters · filed 2015-02-27 | $831.34M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $214.43M 8-K · filed 2014-06-20 | $424.52M derived: sum of 2 quarters · filed 2014-06-20 | $634.69M derived: sum of 3 quarters · filed 2014-06-20 | $830.87M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $210.08M 8-K · filed 2014-06-20 | $420.25M derived: sum of 2 quarters · filed 2014-06-20 | $616.44M 10-Q · filed 2013-10-30 | $819.96M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2012-06-30 | $210.17M 8-K · filed 2014-06-20 | $406.36M 10-Q/A · filed 2013-08-02 | $609.88M derived: sum of 3 quarters · filed 2014-06-20 | $812.06M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2012-03-31 | $196.19M 8-K · filed 2014-06-20 | $399.71M derived: sum of 2 quarters · filed 2014-06-20 | $601.89M derived: sum of 3 quarters · filed 2014-06-20 | $795.22M derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2011-12-31 | $203.52M 10-K · filed 2013-02-26 | $405.71M derived: sum of 2 quarters · filed 2013-02-26 | $599.04M derived: sum of 3 quarters · filed 2013-02-26 | $780.08M 8-K · filed 2014-06-20 | ||||
| 2011-09-30 | $202.19M 10-K · filed 2013-02-26 | $395.51M derived: sum of 2 quarters · filed 2013-02-26 | $576.55M 10-Q · filed 2012-10-24 | $770.69M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $193.33M 10-K · filed 2013-02-26 | $374.37M 10-Q · filed 2012-07-31 | $568.50M derived: sum of 3 quarters · filed 2013-02-26 | $755.14M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $181.04M 10-K · filed 2013-02-26 | $375.18M derived: sum of 2 quarters · filed 2013-02-26 | $561.82M derived: sum of 3 quarters · filed 2013-02-26 | $740.41M derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | $194.13M 10-K · filed 2012-02-27 | $380.77M derived: sum of 2 quarters · filed 2012-02-27 | $559.37M derived: sum of 3 quarters · filed 2012-02-27 | $732.07M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $186.64M 10-K · filed 2012-02-27 | $365.24M derived: sum of 2 quarters · filed 2012-02-27 | $537.93M 10-Q · filed 2011-10-31 | $721.46M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-06-30 | $178.59M 10-K · filed 2012-02-27 | $351.29M 10-Q · filed 2011-08-01 | $534.82M derived: sum of 3 quarters · filed 2012-02-27 | $707.11M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-03-31 | $172.70M 10-K · filed 2012-02-27 | $356.22M derived: sum of 2 quarters · filed 2012-02-27 | $528.51M derived: sum of 3 quarters · filed 2012-02-27 | $694.24M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2009-12-31 | $183.53M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $355.81M derived: sum of 2 quarters · filed 2012-02-27 | $521.54M derived: sum of 3 quarters · filed 2012-02-27 | $682.49M 10-K · filed 2012-02-27 | ||||
| 2009-09-30 | $172.29M 10-Q · filed 2010-10-28 | $338.01M derived: sum of 2 quarters · filed 2010-10-28 | $498.96M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | $165.72M 10-Q · filed 2010-07-29 | $326.68M 10-Q · filed 2010-07-29 | ||||||
| 2008-12-31 | $654.60M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |